as of 12-12-2025 2:23pm EST
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
| Founded: | 2003 | Country: | United States |
| Employees: | N/A | City: | FRAMINGHAM |
| Market Cap: | 14.9M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 8.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.70 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.90 - $10.40 | Next Earning Date: | 10-16-2025 |
| Revenue: | $3,000 | Revenue Growth: | -99.97% |
| Revenue Growth (this year): | -8.47% | Revenue Growth (next year): | 134.88% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
See how PULM stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "PULM Pulmatrix Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.